Table I Index
Table of Contents

Table I - 82
Vanderburgh
Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana

Primary Site

Total

Males Females
Number Rate Number Rate Number Rate
All sites 813 363.1 374 400.1 439 347.4
Oral cavity and pharynx 23 10.4 14 14.2** 9 7.3**
Lip * # * # * #
Tongue * # * # * #
Major salivary glands 5 2.3** * # * #
Floor of mouth * # * # * #
Gum and other mouth * # * # * #
Nasopharynx * # * # * #
Tonsil * # * # * #
Oropharynx * # * # * #
Hypopharynx * # * # * #
Pharynx and other oral cavity * # * # * #
Digestive system 162 69.9 74 78.5 88 65.0
Esophagus 5 2.2** * # * #
Stomach 12 5.2** 7 7.7** 5 3.3**
Small intestine * # * # * #
Colon excluding rectum 88 36.1 42 43.5 46 32.1
Rectum and rectosigmoid 23 10.7 6 6.2** 17 14.5**
Anus, anal canal, and anorectum * # * # * #
Liver and intrahepatic bile duct 10 5.0** 6 6.8** * #
Gallbladder * # * # * #
Other biliary * # * # * #
Pancreas 17 7.7** 9 10.2** 8 5.7**
Retroperitoneum * # * # * #
Peritoneum * # * # * #
Other digestive organs * # * # * #
Respiratory system 157 69.4 97 104.9 60 44.1
Nasal cavity, ear, and sinuses * # * # * #
Larynx 12 5.0** 9 9.2** * #
Lung and bronchus 141 62.9 86 93.7 55 40.3
Trachea, pleura, and other respiratory organs * # * # * #
Bones and joints * # * # * #
Soft tissue (including heart) 6 2.8** 5 5.8** * #
Skin (excluding basal and squamous) 20 9.5 12 12.6** 8 7.3**
Melanoma of the skin 19 9.1** 11 11.6** 8 7.3**
Other non-epithelial skin cancers * # * # * #
Breast 137 64.2 * # 136 114.4
Female genital system 48 22.1 -- -- 48 39.2
Cervix uteri 6 2.9** -- -- 6 5.3**
Corpus uteri 28 12.8 -- -- 28 22.8
Uterus, NOS * # -- -- * #
Ovary 11 5.0** -- -- 11 8.8**
Vagina * # -- -- * #
Vulva * # -- -- * #
Other female genital organs * # -- -- * #
Male genital system 76 32.9 76 80.8 -- --
Prostate gland 72 30.5 72 76.0 -- --
Testis * # * # -- --
Penis * # * # -- --
Other male genital organs * # * # -- --
Urinary system 59 25.0 35 35.9 24 18.7
Urinary bladder 35 13.3 21 20.6 14 8.9**
Kidney and renal pelvis 23 11.3 14 15.3** 9 9.2**
Ureter * # * # * #
Other urinary organs * # * # * #
Eye and orbit * # * # * #
Brain and other nervous system 17 9.3** 13 14.8** * #
Brain 17 9.3** 13 14.8** * #
Other nervous system * # * # * #
Endocrine system 6 3.0** * # 5 4.5**
Thyroid gland 5 2.4** * # 5 4.5**
Other endocrine (including thymus) * # * # * #
Lymphoma 33 15.4 19 21.8** 14 10.1**
Hodgkin’s disease * # * # * #
Non-Hodgkin’s lymphoma 31 14.5 18 20.7** 13 9.2**
Multiple myeloma 9 3.7** * # 7 4.6**
Leukemia 24 11.1 8 8.4** 16 14.3**
Acute lymphocytic * # * # * #
Chronic lymphocytic * # * # * #
Acute myeloid 11 5.6** * # 7 6.9**
Chronic myeloid * # * # * #
Other leukemias * # * # * #
Other, ill-defined and unknown sites 30 11.8 13 12.9** 17 11.1**

1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than twenty cases are unstable.
# Rate cannot be calculated.
_______________________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table I Index
Table of Contents

[an error occurred while processing this directive]